AACR Poster Presentation: “KSQ-001: A CRISPR/Cas9-Engineered Tumor Infiltrating Lymphocyte (eTIL™) Therapy for Solid Tumors

June 22, 2020

AACR Poster Presentation: “KSQ-001: A CRISPR/Cas9-Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy for Solid Tumors

Click to download PDF file.